NFE2L3 and cutaneous melanoma: To complement these results, a significant increase in NRF3 mRNA levels between primary (n = 103) and metastatic cutaneous melanomas (n = 368) was seen in the TIMER2.0 [18] The Cancer Genome Atlas sample set (p value < 0.001, Figure 1(b)).